Biocon's Shaw says Budget boosts India’s health and innovation agenda
Published on: Feb. 1, 2026, 3:18 p.m. | Source: The Economic Times
The Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sector. A new initiative, 'Biopharma Shakti', will receive Rs 10,000 crore over five years. This funding will boost manufacturing, regulation, and clinical trials. The aim is to establish India as a global biopharma manufacturing hub.
